Decrease in emergency room or urgent care visits due to management of bronchial asthma inpatients and outpatients with pharmaceutical services

Journal of Clinical Pharmacy and Therapeutics

Volumn 23, Issue 4, 1998, Pages 303-309

  Watanabe, T ^a   Ohta, M ^b   Murata, M ^b   Yamamoto, T ^a  

^a SHOWA UNIVERSITY   (Japan)

^b NIPPON MEDICAL SCHOOL TAMA NAGAYAMA HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFLAMMATORY AGENT; THEOPHYLLINE;

ADULT; AGED; ARTICLE; ASTHMA; CONTROLLED STUDY; DRUG COST; EMERGENCY WARD; FEMALE; HOSPITAL ADMISSION; HOSPITAL PATIENT; HUMAN; INHALER; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; PHARMACEUTICAL CARE; THEOPHYLLINE BLOOD LEVEL;

ALGORITHMS; ASTHMA; BRONCHODILATOR AGENTS; CASE-CONTROL STUDIES; DRUG COSTS; EMERGENCY SERVICE, HOSPITAL; FEMALE; HUMANS; INPATIENTS; MALE; OUTCOME ASSESSMENT (HEALTH CARE); OUTPATIENTS; PHARMACY SERVICE, HOSPITAL; THEOPHYLLINE;

EID: 0031721186     PISSN: 02694727     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2710.1998.00163.x     Document Type: Article

References (22)

1. Nahata MC. (1489) Hospital pharmacy in Japan. DICP, The Annals of Pharmacotherapy, 23, 334-335.
2. Hepler CD, Strand LM. (1990) Opportunities and responsibilities in pharmaceutical care. American Journal of Hospital Pharmacy, 47, 533-543.
3. American Society of Hospital Pharmacists. (1993) ASHP guidelines on the pharmacist's role in home care. American Journal of Hospital Pharmacy, 50, 1940-1944.
4. Kolb WK. (1995) Pharmacotherapy quality improvement in the managed care setting. Topics in Hospital Pharmacy Management, 14, 8-19.
5. Ryan ML, Chaffee BW. (1995) Development of a continuous quality improvement/total quality management program for medication use monitoring. Topics in Hospital Pharmacy Management, 14, 27-47.
6. Muller RJ, Agre P. (1991) Patient education: a multidisciplinary approach to influence patient compliance. Topics in Hospital Pharmacy Management, 10, 50-55.
7. Horwitz RI, Horwitz SM. (1993) Adherence to treatment and health outcomes. Archives of Internal Medicine, 153, 1863-1868.
8. Kesten S, Zive K, Chapman KR. (1943) Pharmacist knowledge and ability to use inhaled medication delivery system. Chest, 104, 1737-1742.
9. Mickle TR, Self TH, Farr GE, Bess DT, Tsiu SJ, Caldwell FL. (1990) Evaluation of pharmacist's practice in patient education when dispensing a meter-dose inhaler. DICP, The Annals of Pharmacotherapy, 24, 927-930.
10. Lenfant C. (1991) Guidelines for the diagnosis and management of asthma. Journal of Allergy and Clinical Immunology, 88, 425-533.
11. National Heart Lung and Blood Institute. (1997) New NHLBI guidelines for the diagnosis and management of asthma. Lippincott Health Promotion Letters, 2(7), 1.
12. Mackinnon NJ, Flagstand MS, Peterson CR, Mesch-Beatty K. (1996) Disease management program for asthma: baseline assessment of resource use. American Journal of Health - System Pharmacy, 53, 535-541.
13. 2 synthetase inhibitors in the treatment of patients with bronchial asthma. Clinical Therapeutics, 17, 2-11.
14. Barnes NC, Pujet JC. (1997) Pranlukast, a novel leukotriene receptor antagonist: results of the first European, placebo controlled, multicenter clinical study in asthma. Thorax, 52, 523-527.
15. 2-receptor antagonist on bradykinin-induced bronchoconstriction in asthma. Journal of Applied Physiology, 90, 1973-1977.
16. Trakas K, Addis A, Kruk D, Buczek Y, Iskedjian M, Einarson TR. (1997) Quality assessment of pharmacoeconomic abstracts of original researches in selected journals. The Annals of Pharmacotherapy, 31, 423-428.
17. Bootman JL, Harrison DL. (1997) Pharmacoeconomics and therapeutic drug monitoring. Pharmacy World and Science, 19, 178-181.
18. DaSilva RV. (1996) A disease management case study on asthma. Clinical Therapeutics, 18, 1374-1382.
19. Grey RR, Townsend RJ, Sanders CA. (1995) Outcomes measurement. The key to the appropriate use of pharmaceuticals. International Journal of Technology Assessment in Health Care, 11, 472-484.
20. van Roijen L, Essink-Bot ML, Koopmanschap MA, Bonsel G, Rutten FH. (1996) Labor and health status in economic evaluation of health care. The Health and Labor Questionnaire. International Journal of Technology Assessment in Health Care, 12, 405-415.
21. McGliveray IJ. (1993) Overview of current drug intervention in management of asthma: Choices and Concerns. Topics in Pharmaceutical Sciences, 45-62.
22. Kossoy AF, Hill M, Lin FL, Szefler SJ. (1989) Are theophylline 'levels' a reliable indicator of compliance? Journal of Allergy Clinical Immunology, 84, 60-65.